These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38626860)

  • 1. A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines.
    Turuvekere Vittala Murthy N; Vlasova K; Renner J; Jozic A; Sahay G
    Adv Drug Deliv Rev; 2024 Jun; 209():115305. PubMed ID: 38626860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis.
    Villate-Beitia I; Zarate J; Puras G; Pedraz JL
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1071-1081. PubMed ID: 28270008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging gene therapies for cystic fibrosis.
    Miah KM; Hyde SC; Gill DR
    Expert Rev Respir Med; 2019 Aug; 13(8):709-725. PubMed ID: 31215818
    [No Abstract]   [Full Text] [Related]  

  • 4. New approaches to genetic therapies for cystic fibrosis.
    Christopher Boyd A; Guo S; Huang L; Kerem B; Oren YS; Walker AJ; Hart SL
    J Cyst Fibros; 2020 Mar; 19 Suppl 1():S54-S59. PubMed ID: 31948871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of genes into the CF airway.
    Gill DR; Hyde SC
    Thorax; 2014 Oct; 69(10):962-4. PubMed ID: 25015239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee TW; Southern KW; Perry LA; Penny-Dimri JC; Aslam AA
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005599. PubMed ID: 27314455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.
    Suk JS; Kim AJ; Trehan K; Schneider CS; Cebotaru L; Woodward OM; Boylan NJ; Boyle MP; Lai SK; Guggino WB; Hanes J
    J Control Release; 2014 Mar; 178():8-17. PubMed ID: 24440664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy in cystic fibrosis.
    Armstrong DK; Cunningham S; Davies JC; Alton EW
    Arch Dis Child; 2014 May; 99(5):465-8. PubMed ID: 24464978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis.
    Schneider-Futschik EK
    Gene Ther; 2019 Sep; 26(9):354-362. PubMed ID: 31300729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and novel therapeutic strategies for the management of cystic fibrosis.
    Gbian DL; Omri A
    Expert Opin Drug Deliv; 2021 May; 18(5):535-552. PubMed ID: 33426936
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on Genetic Medicine for Cystic Fibrosis.
    Smirnikhina SA
    Curr Gene Ther; 2022; 22(5):386-396. PubMed ID: 35864800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward cystic fibrosis gene therapy.
    Wagner JA; Gardner P
    Annu Rev Med; 1997; 48():203-16. PubMed ID: 9046956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution.
    Konstan MW; Davis PB; Wagener JS; Hilliard KA; Stern RC; Milgram LJ; Kowalczyk TH; Hyatt SL; Fink TL; Gedeon CR; Oette SM; Payne JM; Muhammad O; Ziady AG; Moen RC; Cooper MJ
    Hum Gene Ther; 2004 Dec; 15(12):1255-69. PubMed ID: 15684701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for cystic fibrosis by means of aerosol.
    Rochat T; Morris MA
    J Aerosol Med; 2002; 15(2):229-35. PubMed ID: 12184873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles.
    Comegna M; Conte G; Falanga AP; Marzano M; Cernera G; Di Lullo AM; Amato F; Borbone N; D'Errico S; Ungaro F; d'Angelo I; Oliviero G; Castaldo G
    Sci Rep; 2021 Mar; 11(1):6393. PubMed ID: 33737583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF.
    Egan ME
    Pediatr Pulmonol; 2021 Feb; 56 Suppl 1(Suppl 1):S32-S39. PubMed ID: 32681713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing.
    Maule G; Arosio D; Cereseto A
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is gene therapy in cystic fibrosis a realistic expectation?
    McElvaney NG
    Curr Opin Pulm Med; 1996 Nov; 2(6):466-71. PubMed ID: 9363187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
    Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.